Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 5 Colorectal Neoplasms 4 Colonic Polyps 4 Melanoma 2 Inflammatory Bowel Diseases 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Ovarian Neoplasms 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Intestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Colonic Diseases 1 Adenoma 1

Interventions

Fluorouracil 4 Oxaliplatin 3 Leucovorin 3 Irinotecan 3 Bevacizumab 3 5,10-methylenetetrahydrofolic acid 3 Colonoscopy 2 Capecitabine 2 Bisacodyl 2 trametinib 1 spartalizumab 1 pralsetinib 1 nazartinib 1 napabucasin 1 guadecitabine 1 canakinumab 1 Ursodeoxycholic Acid 1 Tinzaparin 1 Suction 1 Simvastatin 1 Radiotherapy 1 Polyethylene Glycols 1 Pemetrexed 1 Oviposition 1 Ocoxin 1 Mass Screening 1 Levoleucovorin 1 Drainage 1 Cyclophosphamide 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intestinal Neoplasms × Polyethylene Glycols × Clear all

NCT01887158 2014-06-17

PEGOP

Ospedale Santa Maria delle Croci

Phase 4 Completed

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡